Month: April 2015

Andarix Selected to Present at Orphan Drug Congress

Apr 21, 2015

—

by

cadams

in Article

lung cancer, oncology, orphan drug, pancreatic cancer, personalized medicine, radiotherapy, sclc, targeted therapy

ANDARIX Pharmaceuticals, a clinical stage company developing a targeted peptide therapy for small cell lung and other cancers announced that its Chief Executive Officer, Chris Adams, will present at the World Orphan Drug Conference in Washington, DC on April 23, 2015. Conference location and agenda information are available at the World Orphan Drug Congress. Andarix’ lead development…